KENNIE MEDS
Live / Applied — First extension granted (statement of use) (as of 03 Feb 2026)
What this means for you
Not registered yet, but its 12 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99179929
- Mark type
- Stylized text
- Filed
- 12 May 2025
- Published for opposition
- 25 Nov 2025
- Attorney of record
- Andrew Comer
Goods and services
- Class 001 — Chemicals: Calcium carbonate tablets.
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, ibuprofen tablets; acetaminophen tablets; bismuth subsalicylate tablets for pharmaceutical purposes; famotidine tablets; diphenhydramine tablets; guaifenesin tablets; loperamide tablets; hydrocortisone topical cream; fluticasone nasal spray; oxymetazoline nasal spray; saline nasal spray; liquid acetaminophen for children; liquid ibuprofen for children; liquid guaifenesin; azithromycin prescription tablets; ondansetron prescription tablets; cephalexin prescription tablets; hangover herbal supplement capsules; cold and flu herbal supplement capsules; scopolamine patches.
Owner
- Daniel Wandsneider, Denver, CO, US
- Daniel Wandsneider, Denver, CO, US
Prosecution history
- 04 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Feb 2026 — SOU EXTENSION 1 GRANTED
- 03 Feb 2026 — SOU EXTENSION 1 FILED
- 03 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 20 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Nov 2025 — PUBLISHED FOR OPPOSITION
- 19 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Sept 2025 — NON-FINAL ACTION E-MAILED
- 25 Sept 2025 — NON-FINAL ACTION WRITTEN